Patent application number | Description | Published |
20130235744 | COMMUNICATION SYSTEM USING ORBITAL ANGULAR MOMENTUM - Different data communication architectures deliver a wide variety of content, including audio and video content, to consumers. The architectures may utilize orbital angular momentum to deliver more bandwidth across multiple channels than any single communication channel can carry. In some implementations, the communication architectures distribute data across multiple orbital angular momentum channels in a bonded channel group. | 09-12-2013 |
20150103847 | Channel Bonding With Orbital Angular Momentum - Different data communication architectures deliver a wide variety of content, including audio and video content, to consumers. The architectures employ channel bonding to deliver more bandwidth than any single communication channel can carry. In some implementations, the communication architectures distribute data across multiple orbital angular momentum channels in the bonded channel group. | 04-16-2015 |
20150304152 | Communication System Using Orbital Angular Momentum - Different data communication architectures deliver a wide variety of content, including audio and video content, to consumers. The architectures may utilize orbital angular momentum to deliver more bandwidth across multiple channels than any single communication channel can carry. In some implementations, the communication architectures distribute data across multiple orbital angular momentum channels in a bonded channel group. | 10-22-2015 |
Patent application number | Description | Published |
20140355624 | TRANSMITTING MULTIPLE ADAPTIVE BIT RATE (ABR) SEGMENT STREAMS ON A SHARED FREQUENCY - A system for transmitting multiple adaptive bit rate (ABR) segment streams on a shared frequency may include an ABR segment generator and transmitter circuitry. The ABR segment generator may encode a content item based at least in part on different ABR profiles to generate encoded streams. The ABR profiles may indicate encoding parameters corresponding to the encoded streams, e.g., bit rates, resolutions, frame rates and/or codecs. The ABR segment generator may be further configured to segment the encoded streams to generate ABR segment streams. The transmitter circuitry may be configured to transmit the ABR segment streams on a shared frequency, such as by transmitting the segment streams over spatially separated antennas, or by applying different orbital angular momentums to the ABR segment streams. In one or more implementations, the system may further include a segment interleaver that is configured to interleave the ABR segment streams. | 12-04-2014 |
20150319554 | IMAGE TRIGGERED PAIRING - An image triggered pairing system may include at least one processor circuit. The at least one processor circuit may be configured to identify a pairable device within an area. The at least one processor circuit may be further configured to determine a pairing status of the pairable device. The at least one processor circuit may be further configured to provide, for display, a graphical representation of the area and the pairable device that indicates the pairing status of the pairable device. | 11-05-2015 |
20150324698 | CONTEXT-AWARE DECISION MAKING - A context-aware decision making system may include at least one processor circuit that is configured to obtain an environmental profile of an environment associated with a user. The at least one processor circuit is configured to determine a predicted behavior of the user based at least on the obtained environmental profile. The at least one processor circuit may be configured to determine the predicted behavior of the user using at least one predictive model associated with the user. The at least one processor circuit may be configured to perform an action related to the predicted behavior of the user, such as an action that facilitates the predicted behavior of the user, an action that impedes the predicted behavior of the user, and/or an action that provides information related to the predicted behavior of the user. | 11-12-2015 |
Patent application number | Description | Published |
20100010208 | PURIFICATION OF A TRIPLE HELIX FORMATION WITH AN IMMOBILIZED OLIGONUCLEOTIDE - Method for double-stranded DNA purification, by which a solution containing said DNA in a mixture with other components is passed over a support on which is covalently coupled in oligonucleotide capable of hybridizing with a specific sequence present on said DNA to form a triple helix. | 01-14-2010 |
20100061979 | MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WSITH IMPROVED BIOLOGICAL ACTIVITY - The invention relates to modified soluble FGF receptor Fc fusions comprising a fusion of a soluble fragment or domain of the FGF receptor part (targeting or binding moiety) with an Fc region of an immunoglobulin part (effector function moiety), having improved biological activity including ADCC/CDC activities, compositions containing them, and method of producing such modified soluble FGF receptor Fc fusion molecules. | 03-11-2010 |
20110150903 | FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - The present invention relates to FGF-R4 receptor-specific antagonist molecules enabling the inhibition of the activity of said receptor. Said antagonists are, particularly, FGF-R4-specific antibodies enabling the inhibition of the activity of said receptor. The present invention also relates to the therapeutic use of said antibodies, particularly in the field of angiogenesis and in the treatment of certain types of cancer. | 06-23-2011 |
20120177639 | HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE - The present application relates to humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide, and to the use of said antibodies in the field of Alzheimer's disease. | 07-12-2012 |
20120195851 | MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL ACTIVITY - The invention relates to modified soluble FGF receptor Fc fusions comprising a fusion of a soluble fragment or domain of the FGF receptor part (targeting or binding moiety) with an Fc region of an immunoglobulin part (effector function moiety), having improved biological activity including ADCC/CDC activities, compositions containing them, and method of producing such modified soluble FGF receptor Fc fusion molecules. | 08-02-2012 |
20120244152 | NOVEL ANTAGONIST ANTIBODIES AND THEIR FAB FRAGMENTS AGAINST GPVI AND USES THEREOF - The present invention discloses novel antibodies that specifically bind to the human platelet membrane protein Glycoprotein VI (GPVI) and their monovalent fragments or derivatives. The antibodies of the invention are antibodies from hybridoma clone 390 and fragment antibodies thereof able to induce a GPVI depletion pheno-type. These antibodies and Fab fragments are able to block collagen binding and thus preventing platelet activation by collagen. The invention also relates to hybridoma clones and expression plasmids for the production of disclosed antibodies and Fab fragments. The present invention further refers to the uses of monovalent antibody fragments to manufacture research, diagnostic and immunotherapeutic agents for the treatment of thrombosis and other vascular diseases. The invention also concerns a Fab bearing a molecule at the C-terminal extremity, as well as method for prevention of recognition of Fab by antibodies using such modified Fab. The invention concerns a method for prevention of platelet activation when an anti-GP VI Fab is used. | 09-27-2012 |
20120282637 | POLYPEPTIDES FOR BINDING TO THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS AS WELL AS COMPOSITIONS AND METHODS INVOLVING - The present invention relates to a polypeptide or polypeptide complex comprising at least the two amino acid sequences arranged to allow for specific binding to the “receptor for advanced glycation endproducts” (RAGE), one or more nucleic acid(s) coding for the polypeptide or polypeptide complex, a cell producing an antibody against RAGE, a pharmaceutical composition comprising at least one polypeptide or nucleic as defined above, optionally for treating a RAGE-related disease or disorder and a method of diagnosing a RAGE-related disease or disorder. | 11-08-2012 |
20130039912 | ROBO1-FC FUSION PROTEIN AND USE THEREOF FOR TREATING TUMOURS - The present invention relates to a Robo1-Fc recombinant protein and to the use thereof for treating diseases in which a Slit protein is overexpressed, in particular cancer. The invention also relates to a composition including such a recombinant Another aspect of the invention involves using a Robo1-Fc molecule as a diagnostic tool for detecting the overexpression of a molecule belonging to the Slit family in a patient. | 02-14-2013 |
20130108641 | ANTI-GITR ANTIBODIES | 05-02-2013 |
20140030265 | MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS METHOD - The invention relates to modified soluble FGF receptor Fc fusions comprising a fusion of a soluble fragment or domain of the FGF receptor part (targeting or binding moiety) with an Fc region of an immunoglobulin part (effector function moiety), having improved biological activity including ADCC/CDC activities, compositions containing them, and method of producing such modified soluble FGF receptor Fc fusion molecules. | 01-30-2014 |
20140046032 | METHOD OF PRODUCTION OF SIALYLATED ANTIBODIES - The present invention relates to a method for producing an IgG antibody, wherein at least 80% of the said antibody comprises a complex, bi-antennary oligosaccharide, which contains two sialic acid residues, attached to the Fc domain of the antibody. The said method comprises the steps of introducing a mutation in the Fc domain of the antibody, and expressing the mutant antibody in a cell which expresses a galactosyltransferase and a sialyltransferase activity. | 02-13-2014 |
20140105890 | HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE - The present application relates to humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide, and to the use of said antibodies in the field of Alzheimer's disease. | 04-17-2014 |
20150098939 | NOVEL ANTAGONIST ANTIBODIES AND THEIR FAB FRAGMENTS AGAINST GPVI AND USES THEREOF - The present invention discloses novel antibodies that specifically bind to the human platelet membrane protein Glycoprotein VI (GPVI) and their monovalent fragments or derivatives. The antibodies of the invention are antibodies from hybridoma clone 390 and fragment antibodies thereof able to induce a GPVI depletion phenotype. These antibodies and Fab fragments are able to block collagen binding and thus preventing platelet activation by collagen. The invention also relates to hybridoma clones and expression plasmids for the production of disclosed antibodies and Fab fragments. The present invention further refers to the uses of monovalent antibody fragments to manufacture research, diagnostic and immunotherapeutic agents for the treatment of thrombosis and other vascular diseases. The invention also concerns a Fab bearing a molecule at the C-terminal extremity, as well as method for prevention of recognition of Fab by antibodies using such modified Fab. The invention concerns a method for prevention of platelet activation when an anti-GP VI Fab is used. | 04-09-2015 |
20160108131 | ANTI-CEACAM5 ANTIBODIES AND USES THEREOF - The present invention discloses antibodies which bind human and | 04-21-2016 |
Patent application number | Description | Published |
20140252804 | PILLAR COVERING FOR MOTOR VEHICLES - A pillar covering for motor vehicles is described. The pillar covering has a carrier part having an integrated window guide web and a mounting element, a narrowing at the point of contact of the window guide web with the carrier part, and a cover part connected to the carrier part via a contact surface, whereby the carrier part and the cover part form at least one common end portion and the contact surface within the end piece runs over a length of at least 1 mm at a mean angle of 5° to 60° above or below a mean axis along the contact surface outside the end piece. | 09-11-2014 |
20140284954 | PILLAR COVERING FOR MOTOR VEHICLES - A pillar covering for motor vehicles is described. The cover has a carrier part having a projected integrated window guide web and a projecting mounting element, an elevated circular, oval, or polygonal surface structure on the window guide web and/or the mounting element, and a polymer cover part connected to the carrier part via a contact surface. | 09-25-2014 |
20140375073 | PILLAR COVERING FOR MOTOR VEHICLES - A pillar covering for motor vehicles is described. The pillar covering has a carrier part with an integrated window guide web and a mounting element, a narrowing at the point of contact between the window guide web and the carrier part ( | 12-25-2014 |
Patent application number | Description | Published |
20080305549 | LIPOPROTEIN ANALYSIS BY DIFFERENTIAL CHARGED-PARTICLE MOBILITY - The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for assessing lipid-related health risk, cardiovascular condition, risk of cardiovascular disease, and responsiveness to a therapeutic intervention, which methods utilize lipoprotein size distributions determined by methods of the invention. | 12-11-2008 |
20100213061 | ION MOBILITY ANALYSIS OF LIPOPROTEINS - A medical diagnostic method and instrumentation system for analyzing noncovalently bonded agglomerated biological particles is described. The method and system comprises: a method of preparation for the biological particles; an electrospray generator; an alpha particle radiation source; a differential mobility analyzer; a particle counter; and data acquisition and analysis means. The medical device is useful for the assessment of human diseases, such as cardiac disease risk and hyperlipidemia, by rapid quantitative analysis of lipoprotein fraction densities. Initially, purification procedures are described to reduce an initial blood sample to an analytical input to the instrument. The measured sizes from the analytical sample are correlated with densities, resulting in a spectrum of lipoprotein densities. The lipoprotein density distribution can then be used to characterize cardiac and other lipid-related health risks. | 08-26-2010 |
20110089037 | BIOLOGICAL PARTICLES - A medical diagnostic method and instrumentation system for analyzing noncovalently bonded agglomerated biological particles is described. The method and system comprises: a method of preparation for the biological particles; an electrospray generator; an alpha particle radiation source; a differential mobility analyzer; a particle counter; and data acquisition and analysis means. The medical device is useful for the assessment of human diseases, such as cardiac disease risk and hyperlipidemia, by rapid quantitative analysis of lipoprotein fraction densities. Initially, purification procedures are described to reduce an initial blood sample to an analytical input to the instrument. The measured sizes from the analytical sample are correlated with densities, resulting in a spectrum of lipoprotein densities. The lipoprotein density distribution can then be used to characterize cardiac and other lipid-related health risks. | 04-21-2011 |
20120315706 | LIPOPROTEIN ANALYSIS BY DIFFERENTIAL CHARGED-PARTICLE MOBILITY - The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for assessing lipid-related health risk, cardiovascular condition, risk of cardiovascular disease, and responsiveness to a therapeutic intervention, which methods utilize lipoprotein size distributions determined by methods of the invention. | 12-13-2012 |
20140287530 | LIPOPROTEIN ANALYSIS BY DIFFERENTIAL CHARGED-PARTICLE MOBILITY - The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for assessing lipid-related health risk, cardiovascular condition, risk of cardiovascular disease, and responsiveness to a therapeutic intervention, which methods utilize lipoprotein size distributions determined by methods of the invention. | 09-25-2014 |
20150260739 | LIPOPROTEIN ANALYSIS BY DIFFERENTIAL CHARGED-PARTICLE MOBILITY - The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for assessing lipid-related health risk, cardiovascular condition, risk of cardiovascular disease, and responsiveness to a therapeutic intervention, which methods utilize lipoprotein size distributions determined by methods of the invention. | 09-17-2015 |
Patent application number | Description | Published |
20090046333 | System and Method Using a Voltage Kick-Off to Record a Hologram on a Photorefractive Polymer for 3D Holographic Display and Other Applications - An updateable system and method of recording a hologram on a media simultaneously reduces the writing time and increases persistence without sacrificing diffraction efficiency. A voltage kick-off technique controls the bias electric field applied to a photorefractive polymer media in conjunction with the application of the writing beams and dark decay. Essentially the voltage kick-off technique applies a high electric field above the optimal field while the writing beams are on and reduces the electric field when the writing beams are off during dark decay. The voltage kick-off technique produced two separate unexpected results. First, when the writing beams are turned off and the electric field is lowered the diffraction efficiency continues to increase until it reaches a maximum efficiency that is within a few percent of that achieved by writing at the optimal field until steady-state is achieved. Second, the decay time constant is much larger than expected producing a much longer persistence without sacrificing diffraction efficiency or writing time. | 02-19-2009 |
20110199658 | System and method for synchronizing a spatial light modulator with a pulsed laser to record a hologram at the repetition rate of the pulsed laser - A system and method that synchronizes a spatial light modulator (SLM) with a pulsed laser to record a hologram at the repetition rate of the pulsed laser for applications including holographic displays and data storage. The color channel capability of a SLM is utilized to effectively increase the write throughput when the pulsed laser repetition rate LR exceeds the SLM's image refresh rate R. The hogels are encoded on the color channels and concatenated to form a sequence of color images such that the write throughput is equal to the repetition rate LR up to a maximum of N*R. The invention effectively extends the capability and continued viability of existing inexpensive SLMs. | 08-18-2011 |
20110228040 | Auto Stereoscopic 3D Telepresence Using Integral Holography - A holographic direct-view display system uses holographic integral imaging techniques that is an auto stereoscopic way to reproduce parallax and occlusion. The display is not resolution limited and is scalable to display life size images if desired. The system can be used to transmit 3D depictions of a scene at video and sub-video rates as well as other information, such as images of documents or computer generated images. The images may be captured, transmitted and displayed in real-time (or near real-time) for telepresence or stored for time-shifted display. The system combines integral holography, a pulsed laser to record the hologram at high speed and a dynamic refreshable holographic material such as a photorefractive polymer as a recording media. The system uses techniques to write, read and erase the updateable hologram that allow the holographic material, hence direct-view display to remain stationary throughout each of the processes for continuous presentation of the hologram to the audience. The system may write, read and erase at the same time and continuously to increase throughput. This system may also use additional novel techniques to improve brightness, efficiently implement a full-parallax display and to implement a full-color display in a transmission geometry. | 09-22-2011 |
20120008482 | SYSTEM FOR HOLOGRAPHY - The present invention provides systems of recording holograms that reduce the writing time, increase the diffraction efficiency, improve the resolution, or restitute color. These systems are well suited for use with an updateable 3D holographic display using integral holography and photorefractive polymer. | 01-12-2012 |